- Home
- WBX vs COYA Comparison
WBX vs COYA Comparison
Compare WBX & COYA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WBX
- COYA
- Stock Information
- Founded
- WBX 2015
- COYA 2020
- Country
- WBX Spain
- COYA United States
- Employees
- WBX N/A
- COYA N/A
- Industry
- WBX Industrial Specialties
- COYA Biotechnology: Pharmaceutical Preparations
- Sector
- WBX Consumer Discretionary
- COYA Health Care
- Exchange
- WBX Nasdaq
- COYA Nasdaq
- Market Cap
- WBX 85.1M
- COYA 99.8M
- IPO Year
- WBX N/A
- COYA 2022
- Fundamental
- Price
- WBX $5.93
- COYA $5.84
- Analyst Decision
- WBX Buy
- COYA Strong Buy
- Analyst Count
- WBX 3
- COYA 4
- Target Price
- WBX $14.33
- COYA $16.50
- AVG Volume (30 Days)
- WBX 18.7K
- COYA 76.7K
- Earning Date
- WBX 07-31-2025
- COYA 08-11-2025
- Dividend Yield
- WBX N/A
- COYA N/A
- EPS Growth
- WBX N/A
- COYA N/A
- EPS
- WBX N/A
- COYA N/A
- Revenue
- WBX $171,352,140.00
- COYA $3,685,107.00
- Revenue This Year
- WBX N/A
- COYA $21.49
- Revenue Next Year
- WBX $44.10
- COYA N/A
- P/E Ratio
- WBX N/A
- COYA N/A
- Revenue Growth
- WBX 3.75
- COYA N/A
- 52 Week Low
- WBX $4.60
- COYA $4.65
- 52 Week High
- WBX $32.80
- COYA $10.24
- Technical
- Relative Strength Index (RSI)
- WBX 83.14
- COYA 53.73
- Support Level
- WBX $5.92
- COYA $5.71
- Resistance Level
- WBX $6.25
- COYA $6.20
- Average True Range (ATR)
- WBX 0.26
- COYA 0.35
- MACD
- WBX 0.20
- COYA 0.00
- Stochastic Oscillator
- WBX 91.95
- COYA 52.43
About WBX Wallbox N.V.
Wallbox NV is a smart electric vehicle charging and energy management company. It creates a smart charging system combining technology design that manages the communication between the user, vehicle, grid, building, and charger. The company designs, manufactures, and distributes faster, simpler EV charging solutions for residential, business, and public use. Its smart charging product portfolio includes Level 2 alternating current chargers for home and business applications and direct current fast chargers for public applications. The company has three reportable operating segments; Europe, Middle East and Asia (EMEA), its key revenue-generating segment, North America, and Asia-Pacific.
About COYA Coya Therapeutics Inc.
Coya Therapeutics Inc is a clinical-stage biotechnology company focused on developing proprietary medicinal products to modulate the function of regulatory T cells. It is developing its multi-modality Treg therapies for neurodegenerative, autoimmune, and metabolic diseases.